In collaboration with Clark & Elbing, LLP, a Boston-based intellectual property law firm that focuses its practice on biotechnology, medicine, and chemistry, the Harvard Biotech Club will be organizing a 5-week Patent Law Info-course for students and postdocs with life science backgrounds.

Screen Shot 2018-01-22 at 4.33.58 PM.png

When:  4:00-5:30 Thursdays, March 8 - April 5, 2018

Where: Clark & Elbing office, 101 Federal Street, 15th Floor, Boston, MA 02110

Registration:  This course will be limited to 25 people maximum. To ensure that the limited number of spots are given to those who are committed to attending the course in its entirety, $50 deposit checks will be required for attendance. Checks will be returned to those who attend 4 out of 5 sessions.

How to secure a spot in the course:

  1. The Pre-App deadline has past. 
  2.  Applications have been sent to candidates that completed the Pre-App. Those applications are due by 5PM Tuesday, February 20, 2018
  3. Final roster of the course will be sent out no later than February 22, 2018 (two weeks prior to the start of the course)
  4. Please bring $50 deposit checks to the first class on March 8, 2018.

Food will be provided at each class.

Questions? Email hbcpatentlaw@gmail.com


Course Information:

The Patent Law Info-course features a combination of lecture and workshop styles. The first few lecture sessions will introduce students to the patent system and patents in general. It will expose students to important elements of patent law through discussion of court cases and introduce students with the teaching style common to U.S. law schools. The workshop is designed to familiarize students to life in a patent law firm, where students will be introduced to tasks frequently performed by patent agents and patent attorneys, such as drafting a patent application, and conducting a Freedom to Operate Search.  

The course will be conducted by Michael Belliveau from Clark & Elbing, LLP and Forrester Liddle from Jounce Therapeutics. 

Instructor Bios:


Michael Belliveau has been at Clark+Elbing since 1998 and a partner since 2006. His work involves patent prosecution and opinion work, including the preparation of patentability, non-infringement, and freedom-to-operate opinions. Michael works with clients to protect innovations related to small molecule therapeutics for the treatment of bacterial and fungal infections, cancer, neurological disorders, and inflammation; drug discovery; molecular diagnostics; stem cells; and human gene therapy. He also performs patent due diligence analyses for venture capital investors.  Michael graduated with a Ph.D. in Neurobiology from Harvard University in 1998 and with a J.D. from Suffolk University in 2004.




Forrester J. Liddle is Director of Intellectual Property at Jounce Therapeutics.  Mr. Liddle graduated with a Ph.D. in Cell Biology from Harvard University in 2005 and with a J.D. from Suffolk University in 2011.  Mr. Liddle is a member of the Massachusetts State Bar.  Prior to his work at Jounce, Mr. Liddle was a Patent Agent/Associate at Clark and Elbing, LLP between 2005 and 2014 and a Patent Attorney at the Novartis Institutes for BioMedical Research between 2014 and 2016.  Throughout his career, Mr. Liddle has practiced patent law related to therapies related to cancer.